Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
Journal of Natural Products
|
October 22, 2014
Polyyne hybrid compounds from Notopterygium incisum with peroxisome proliferator-activated receptor gamma agonistic effects
Xin Liu, Olaf Kunert, Martina Blunder, et al.
Elife
|
December 3, 2019
Modulating FOXO3 transcriptional activity by small, DBD-binding molecules
Judith Hagenbuchner, Veronika Obsilova, Teresa Kaserer, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
December 24, 2021
Evaluation of the biological and physicochemical properties of calcium silicate-based and epoxy resin-based root canal sealers
Gabriela Cardoso Ferreira, Lucas Siqueira Pinheiro, Júlia Silveira Nunes, et al.
Bioorganic Chemistry
|
July 7, 2023
Novel thiazolopyridine derivatives of diflapolin as dual sEH/FLAP inhibitors with improved solubility
Martin Schoenthaler, Lorenz Waltl, Thomas Hasenoehrl, et al.
Plants (Basel, Switzerland)
|
November 27, 2021
Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
Adriana Trifan, Andra-Cristina Bostănaru, Simon Vlad Luca, et al.
Plos One
|
May 1, 2013
Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma
Atanas G Atanasov, Martina Blunder, Nanang Fakhrudin, et al.
Oncogene
|
October 9, 2019
A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma
Stefan Salcher, Gilles Spoden, Judith Hagenbuchner, et al.
Metabolites
|
February 25, 2022
Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
Gabriele Möller, Veronika Temml, Antonio Cala Peralta, et al.
Journal of Natural Products
|
March 21, 2017
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2
Anna Vuorinen, Roger T Engeli, Susanne Leugger, et al.
Monatshefte Fur Chemie
|
April 13, 2016
Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project
Birgit Waltenberger, Atanas G Atanasov, Elke H Heiss, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
Journal of Natural Products
|
October 22, 2014
Polyyne hybrid compounds from Notopterygium incisum with peroxisome proliferator-activated receptor gamma agonistic effects
Xin Liu, Olaf Kunert, Martina Blunder, et al.
Elife
|
December 3, 2019
Modulating FOXO3 transcriptional activity by small, DBD-binding molecules
Judith Hagenbuchner, Veronika Obsilova, Teresa Kaserer, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
December 24, 2021
Evaluation of the biological and physicochemical properties of calcium silicate-based and epoxy resin-based root canal sealers
Gabriela Cardoso Ferreira, Lucas Siqueira Pinheiro, Júlia Silveira Nunes, et al.
Bioorganic Chemistry
|
July 7, 2023
Novel thiazolopyridine derivatives of diflapolin as dual sEH/FLAP inhibitors with improved solubility
Martin Schoenthaler, Lorenz Waltl, Thomas Hasenoehrl, et al.
Plants (Basel, Switzerland)
|
November 27, 2021
Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
Adriana Trifan, Andra-Cristina Bostănaru, Simon Vlad Luca, et al.
Plos One
|
May 1, 2013
Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma
Atanas G Atanasov, Martina Blunder, Nanang Fakhrudin, et al.
Oncogene
|
October 9, 2019
A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma
Stefan Salcher, Gilles Spoden, Judith Hagenbuchner, et al.
Metabolites
|
February 25, 2022
Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
Gabriele Möller, Veronika Temml, Antonio Cala Peralta, et al.
Journal of Natural Products
|
March 21, 2017
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2
Anna Vuorinen, Roger T Engeli, Susanne Leugger, et al.
Monatshefte Fur Chemie
|
April 13, 2016
Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project
Birgit Waltenberger, Atanas G Atanasov, Elke H Heiss, et al.
Page
of 17